Drug Information

Drug General Information
Drug ID
D06DUS
Former ID
DNCL003505
Drug Name
PVX-410
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Phase 1 [524108]
Target and Pathway
Target(s) SLAM family member 7 (SLAMF7) (CS1) Target Info Modulator [530353], [533177]
References
Ref 524108ClinicalTrials.gov (NCT01718899) Phase 1/2a Study of Cancer Vaccine to Treat Smoldering Multiple Myeloma. U.S. National Institutes of Health.
Ref 530353Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma. Mol Cancer Ther. 2009 Sep;8(9):2616-24.
Ref 533177Market watch: Upcoming catalysts in Q2 2015. Nat Rev Drug Discov. 2015 Apr;14(4):228.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.